Drug companies' leaflets dubbed “confusing”BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7253.72/b (Published 08 July 2000) Cite this as: BMJ 2000;321:72
- Roger Dobson
Drug companies are being urged to improve their product information leaflets for patients after a report from the Consumers Association warning that they can cause confusion and alarm.
Many of the leaflets were found to have so much information crammed into them that they were illegible, while some had too much technical and medical jargon. Others were found to contain vague and sometimes contradictory statements.
The reports said …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial